PTC THERAPEUTICS, INC. (PTCT) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for PTC THERAPEUTICS, INC. (PTCT): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 48/100 — a percentile rank of PTC THERAPEUTICS, INC.’s fundamentals against Manufacturing peers, weakest on growth. A quality ranking, not a price prediction.
| Market cap | $5.4B |
| P / S | 5.3× |
| EV / EBITDA | 28.4× |
| Gross margin | 93.0% |
| Operating margin | 12.5% |
| Net margin | -3.8% |
| Return on equity | 23.2% |
| ROIC | -11.7% |
| Revenue growth | -42.8% |
| Debt / equity | -3.6× |
| Dividend yield | 0.0% |
Is PTC THERAPEUTICS, INC. overvalued? P/S looks overvalued vs its 5-year range.
Independent of the events above — derived from PTC THERAPEUTICS, INC.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact